Filing Flows › Companies › Kinder Morgan › Analysis traps
Kinder Morgan (KMI): analysis traps
Where its figures could mislead a reader, and what to check before taking them at face value · Data: Q3 2026, to Sep 30, 2026, filed Oct 23, 2026; rules v1.1
Kinder Morgan (KMI): 0 rules of 10 triggered on the filings to Sep 30, 2026. 2 to review; 3 with insufficient data; 2 not applicable. Each is a question to verify, with the normal explanation that would produce the same figures.
Check these first
Low P/E at a cyclical peak = undervalued To review · confidence medium
Net income of $3.6B is at a high against a median of $2.4B over eight years; at 18.5× the market is not pricing it as cheap, but a multiple on this year's profit still understates the mid-cycle one (27.9×).
A precise DCF value = the true value To review · confidence high
The DCF's point value is 31.21 a share (price 29.96); 83% of it is the terminal value, a number about years no one has seen. Moving wacc by ±1 pt alone takes it from 21.87 to 46.80; across every method the research ran the range is -4 to 249. The value is a range; the decimals are not information.
Innocent reading: A stable, mature business with a narrow range of outcomes, where the point value is a fair summary.
Every rule
A01 FCF growth = the business improved Not triggered confidence high
Free cash flow did not rise ($3.0B → $2.9B): the trap does not arise.
The figures and how they are read
| Fiscal year before | FY2024 |
| Fiscal year | FY2025 |
| Operating cash flow, year before | $5.6B |
| Operating cash flow | $5.9B |
| Capex, year before | $2.6B |
| Capex | $3.0B |
| Free cash flow, year before | $3.0B |
| Free cash flow | $2.9B |
| Change in FCF | −$115M |
| Change in capex | $397M |
| Working capital: change in its cash contribution | $17M |
FCF = operating cash flow − cash capex; ΔFCF = ΔOCF − ΔCapEx; the working-capital part is the change in the cash-bridge items (receivables, inventory, payables, accruals), with the sign of the cash flow statement
Source: FY2025 (cash flow statement, fiscal year) · FY2024 (cash flow statement, fiscal year before)
A07 Stock compensation added back = no economic cost Insufficient data
fewer than two fiscal years of stock compensation and share counts on file
B02 Receivables growing = future cash is certain Insufficient data
fewer than five quarters with receivables and revenue on file (a year-over-year comparison needs five)
B08 Adjusted profit = economic profit Insufficient data
no reconciliation table read from the releases yet and fewer than three quarters with both an adjusted and a GAAP EPS
C02 Low net debt = no refinancing risk Not triggered confidence medium
$1.2B comes due within a year, 3.3× covered by cash and investments of $918M plus $3.1B of free cash flow.
The figures and how they are read
| Cash and investments | $918M |
| Debt | $33.1B |
| Net debt | $32.2B |
| Due within a year | $1.2B |
| Read from | the debt maturity table |
| Free cash flow, twelve months | $3.1B |
| Cash plus free cash flow | $4.0B |
| Coverage of what is due | 3.3 |
| Due in the second year | $942M |
| Balance sheet date | 2026-09-30 |
due within a year from the maturity table (else the current portion of debt), against cash and investments plus free cash flow over the last twelve months (zero if negative); no credit lines assumed
Source: FY2025 (debt maturities, cash and investments)
D03 EPS growth = profit growth Not triggered confidence high
EPS rose 22% and net income rose 22% in Q3 2026; the share count rose 0.1%: EPS growth follows profit growth.
The figures and how they are read
| Quarter | Q3 2026 |
| Quarter before | Q3 2025 |
| EPS, year before | $0.28 |
| EPS | $0.34 |
| Net income, year before | $628M |
| Net income | $764M |
| Diluted shares, year before | 2,224.0M shares |
| Diluted shares | 2,227.0M shares |
| EPS growth | +21.6% |
| Net income growth | +21.7% |
| Diluted shares: change | +0.1% |
| eps from profit | $0.06 |
| eps from share count | $0.00 |
EPS and net income against the same quarter a year earlier; the EPS bridge attributes the change to profit first, then to the share count (the order is fixed and disclosed)
Source: Q3 2026 (net income, diluted shares, EPS) · Q3 2025 (the same quarter a year earlier)
E02 Low P/E at a cyclical peak = undervalued To review confidence medium
Net income of $3.6B is at a high against a median of $2.4B over eight years; at 18.5× the market is not pricing it as cheap, but a multiple on this year's profit still understates the mid-cycle one (27.9×).
The figures and how they are read
| market value | $66.7B |
| net income ttm | $3.6B |
| pe ttm | 18.50 |
| net income median fy | $2.4B |
| pe mid cycle | 27.90 |
| net income peak fy | $3.1B |
| years | FY2018 / 1609.0; FY2019 / 2190.0; FY2020 / 119.0; FY2021 / 1784.0; FY2022 / 2548.0; FY2023 / 2391.0; FY2024 / 2613.0; FY2025 / 3056.0 |
| down years in window | 2 |
P/E on the trailing twelve months' net income against the P/E on the median net income of the last eight fiscal years (a mid-cycle stand-in); 'at a peak' = this year's profit at or above 90% of the best year and at least 1.3× the median
Source: Q3 2026 (net income, trailing twelve months)
What would show the trap does not apply
- Profit holds at this level through the next two years (the eight-year peak was a new base, not a top)
- The industry's capacity and prices stay where they are rather than reverting
Look again: next filing.
E07 A precise DCF value = the true value To review confidence high
The DCF's point value is 31.21 a share (price 29.96); 83% of it is the terminal value, a number about years no one has seen. Moving wacc by ±1 pt alone takes it from 21.87 to 46.80; across every method the research ran the range is -4 to 249. The value is a range; the decimals are not information.
The figures and how they are read
| dcf value | 31.21 |
| price | 29.96 |
| terminal value share | +83.4% |
| swing by input | WACC / ±1 pt / 21.87 / 46.8; Revenue growth (each year) / ±5 pts / 22.22 / 41.96; Operating margin / ±3 pts / 26.18 / 36.25; Tax rate / ±5 pts / 28.1 / 34.32 |
| range all methods | -3.72; 248.89 |
the DCF's point value against the share of it that is the terminal value and the value at each input moved by one step (growth ±5 pts, WACC ±1 pt, margin ±3 pts …); the range across every method the research ran
Source: 2026-11-08 (valuation research)
What would explain it innocently
- A stable, mature business with a narrow range of outcomes, where the point value is a fair summary
- The inputs that matter most are themselves well known (a regulated return, a long contract)
What to look for in the filing
- Which input you believe differs from the research's and why
- What the price implies for growth (the reverse DCF on the fair-value page)
What would show the trap does not apply
- The DCF's value is robust to the terminal growth and discount rate (the range's low end is still above the price)
- The company's cash flows over the next three years track the DCF's early years
Look again: next filing.
J06 A bank's low P/E and high profit = safe Not applicable
not a bank
J08 A REIT's low net income = the dividend is unsafe Not applicable
not a REIT
What the statuses mean
Triggered: the filings show the pattern; read the normal explanations and the missing evidence before concluding anything. To review: one quarter or a weak signal; a reader's judgement, not a pattern. Not triggered: the pattern is absent on these figures. Insufficient data: the filings read so far do not hold what the rule needs; this is not a clean bill. Not applicable: the rule is not meant for this kind of company (a bank's working capital, a loss-making quarter's EPS growth). Out of date: the latest filing is more than fifteen months old.
Severity is what the pattern could mean for cash, value or solvency; confidence is how reliable the inputs and the reading are. The two are kept apart.
Record a view
A reader's judgement, grounds, what would change it and the next review; kept in the browser (needs JavaScript).
Every rule and the companies it triggers on → Kinder Morgan: cash flow → Earnings quality score →
Each rule reads the company's own filings by a fixed formula and says what would explain the same figures innocently. A triggered rule is a question to verify, not a finding of manipulation, and not a view on the stock. Missing data is shown as missing, never as clear. Not investment advice.